Giulia Fracassi

[Francesca Demichelis @FrancescaBZNY]

Favorite study!

Germline-somatic tandems dictate cancer subtypes, provide clinical insights, and fuel molecularly informed studies.

Kudos: Blerta Stringa,
@Paola_Gasperini, Alessandro Alaimo, and
@LunardiLabCIBIO (co-last a!)
@NimaSharifiMD
https://t.co/cIHAS4PWFC
@UniTrento

[Thomas Cantore @cantore_thomas]

❗️Excited to share my PhD work in Genome Biology: PRODE recovers essential and context-essential genes through neighborhood-informed scores.

What is PRODE, and how does it help?👇

[Journal of Clinical Investigation @jclinicalinvest]

How can we make PARP inhibitors more effective in castration-resistant prostate cancer?

@FrancescaBZNY et al. identify the DNA repair gene LIG1 as a sensitizer to PARP inhibitors in multiple tumor models: https://t.co/6sQHKgmCOJ

@FraLo05 @GiuliaFracassi_ @CIBIO_UniTrento @AIRC_it @PCF_Science @ERC_Research

[Giulia Fracassi @GiuliaFracassi_]

💡Additional Insights:
* LIG1 loss to be considered/analyzed for/in PARPi treatment
* Additional markers to be studied, including EME1 loss and FAAP24 loss

[Giulia Fracassi @GiuliaFracassi_]

🚨 New Preprint Alert! 🚨

I’m thrilled to share our latest study now online on JCI: 
CRISPR/Cas9 screens identify LIG1 as a sensitizer of PARP inhibitors in castration-resistant prostate cancer.

🔬 Check out the preprint here: https://t.co/Svr0nSY1CF

Huge thanks to @FrancescaBZNY, @FraLo05, all Demichelis’ lab members and facilities staff at @UniTrento @CIBIO_UniTrento, and key collaborators @quimmateo, @FdAdF66 and Helmut Klocker.

Special thanks to Fondazione Trentina per la Ricerca sui Tumori, @AIRC_it fellowship, @ERC_Research, @PCF_Science, and MIUR.

#ProstateCancer #CRPC #LIG1 #PARPi #Biomarker #SyntheticLethality #PrecisionMedicine

[Giulia Fracassi @GiuliaFracassi_]

🔑 Key Findings:
* LIG1 loss is synthetically lethal with PARP inhibition.
* LIG1 is altered in 6% of CRPC patients.
* Combined LIG1 and PARP inhibition triggers replication stress and DNA damage, ultimately leading to apoptosis.
* LIG1-PARP synthetic lethality is conserved across various cancers, including prostate, lung, breast, and colorectal.
* Co-targeting LIG1 and PARP selectively impacts PCa and breast cancer cell viability.

[Giulia Fracassi @GiuliaFracassi_]

I am grateful to have been awarded the EMBO Molecular Medicine poster prize! Thank you @EmboMolMed for this, and thank you @pezcoller for organizing such an outstanding symposium.
An enormous thank you also to @FrancescaBZNY and @FraLo05 for their invaluable and constant support.

[Fondazione Pezcoller @pezcoller]

The recipient of @embojournal Molecular Medicine poster prize is:
Fracassi Giulia @GiuliaFracassi_

@CIBIO_UniTrento @UniTrento

[Gian Marco Franceschini @GMFranceschini]

I am beyond excited to see our work out in @CD_AACR . We established a targeted sequencing assay to non-invasively monitor treatment resistance in advanced prostate cancer. Want to know more? Let’s take a short walk 👣

https://t.co/zKlDZe0Dsh

[Francesca Lorenzin @FraLo05]

Our brand new review on the Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer is out!! With @FrancescaBZNY

Have a look at it here: https://t.co/9JTyawdDXa #mdpicancers via @Cancers_MDPI

[Yari Ciani @YariCiani]

The Demichelis Lab ( @FrancescaBZNY ) effort for characterizing the allele-specific landscape of cancer genomes is available as #preprint through the Cell Press Sneak Peek! @ERC_Research #SPICE
https://t.co/ht51Cik2D4

[CIBIO - UniTrento @CIBIO_UniTrento]

📢 A post-master fellow is sought in the #Computational and Functional #Oncology lab of @FrancescaBZNY to study the roles of TMPRSS2-ERG in advanced #cancers.

🗓 Deadline: January, 15th 2021
⬇️ Find more details in the flyer

[Gian Marco Franceschini @GMFranceschini]

So great to see this out as a preprint! 2 years of dense meetings and tons of analyses with @benelli_matteo @romagnoliDario Alberto Magi @FrancescaBZNY . So here it goes my (first) tweetorial 🚀🚀🚀
https://t.co/zfrhiBP4Q0
1/🧵

https://t.co/6BeprrBuD1

[Francesca Demichelis @FrancescaBZNY]

Mini-review on the Evolution of the #prostatecancer genome towards
resistance by Francesca Lorenzin @FraLo05 @CIBIO_UniTrento in the Journal of Translational Genetics and Genomics https://t.co/uvQsOTx26G

[CIBIO - UniTrento @CIBIO_UniTrento]

Meet our PhD students!
#PhD #PhDlife #CIBIOPhD

[CIBIO - UniTrento @CIBIO_UniTrento]

@Ragionevo1Mente is organizing the 2nd Pink Hour with LILT Trento to support correct medical information in cancer and donate oncologic hairpieces to patients. Wednesday, October 17 at 18.30pm at the Buonconsiglio Castle. Let's give them all the help we can!

[The Nobel Prize @NobelPrize]

BREAKING NEWS
The 2018 #NobelPrize in Physiology or Medicine has been awarded jointly to James P. Allison and Tasuku Honjo “for their discovery of cancer therapy by inhibition of negative immune regulation.”

[RagionevolMente @Ragionevo1Mente]

Pronti per la @NotteRicercaTN! Vieni a trovare i nostri volontari @orsaQ @BacilluSubtilis @GiuliaFracassi_ @Azufre451 allo stand 43 del @MUSE_Trento ! #EuropeanResearchersNight #nottedeiricercatori

[Tgr Rai Trentino @TgrRaiTrentino]

#Ricerca contro il #Cancro
finanziamento da 5milioni e 700mila euro per Francesca #Demichelis ricercatrice @CIBIO_UniTrento .
Sta studiando un esame del sangue che aiuti a selezionare il trattamento per pazienti con cancro alla prostata avanzato.

[RagionevolMente @Ragionevo1Mente]

Giornata di riprese oggi a #Trento per il nostro progetto #diamociuntaglio #untaglioragionevole @BacilluSubtilis @LILTnazionale

Seguici su https://t.co/m0kWZmA7ng

[RagionevolMente @Ragionevo1Mente]

Con la terza serata abbiamo conluso #TumoriETimori a #Trento parlando di stili di vita e cattive abitudini. Grazie a tutti per avere partecipato, alla prossima! @CIBIO_UniTrento @UniTrento @giornaleladige @ildolomiti @ProvinciaTrento @LILTnazionale